Myopia And Presbyopia Treatment Market Size 2024-2028
The myopia and presbyopia treatment market size is forecast to increase by USD 9.76 billion at a CAGR of 9.05% between 2023 and 2028.
- The market is experiencing significant growth due to the increasing prevalence of these vision conditions. According to recent studies, myopia affects approximately 2.6 billion people worldwide, and presbyopia, which typically begins around the age of 40, impacts nearly every adult. This burgeoning population of individuals requiring vision correction presents a substantial market opportunity. Simultaneously, recent advancements in myopia and presbyopia treatment are driving innovation and improving patient outcomes. For instance, the emergence of orthokeratology lenses and multifocal contact lenses offers non-surgical alternatives to correct myopia and presbyopia, respectively. Moreover, refractive surgery procedures such as LASIK and PRK continue to evolve, providing increasingly precise and effective solutions for vision correction.
- However, the high cost of myopia and presbyopia treatment remains a significant challenge. While these advancements offer numerous benefits, they often come with a premium price tag. Additionally, regulatory hurdles impact adoption, as stringent regulations and lengthy approval processes can delay market entry for new treatments and technologies. Furthermore, supply chain inconsistencies can temper growth potential, as fluctuations in raw material availability and pricing can impact production and distribution. To capitalize on the market opportunities and navigate these challenges effectively, companies must focus on developing cost-effective solutions while maintaining quality and efficacy. Collaborating with regulatory bodies and optimizing supply chain management can also help mitigate regulatory hurdles and supply chain inconsistencies, respectively.
- By addressing these challenges and leveraging the growing demand for myopia and presbyopia treatments, companies can position themselves for long-term success in this dynamic market.
What will be the Size of the Myopia And Presbyopia Treatment Market during the forecast period?
- The market encompasses various technologies and approaches, including corneal topography, lens physiology, and custom lens implants. Visual disturbances and side effects are key considerations in this market, with a focus on improving functional vision and quality of life. Corneal biomechanics and eye physiology play crucial roles in understanding the underlying causes of refractive errors. Advancements in excimer and femtosecond lasers enable personalized lens design based on ocular anatomy and biometry. Adaptive optics and wavefront analysis enhance surgical precision, while scleral lenses offer solutions for corneal ectasia and irregular astigmatism. Contrast sensitivity and visual performance are essential metrics for driving vision and night vision assessment.
- Ocular biomechanics and optical coherence tomography contribute to ensuring patient safety and optimizing post-operative care. Custom lens implants cater to individual needs, addressing reading vision and presbyopia. The market continues to evolve, with a growing emphasis on improving visual performance and enhancing overall patient experience.
How is this Myopia And Presbyopia Treatment Industry segmented?
The myopia and presbyopia treatment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Type
- Myopia treatment
- Presbyopia treatment
- Product
- Lenses and glass
- Surgery
- Drug
- Treatment Type
- Prescription Lenses
- Contact Lenses
- Surgery
- Medication
- Geography
- North America
- US
- Canada
- Europe
- Germany
- APAC
- China
- Japan
- Rest of World (ROW)
- North America
By Type Insights
The myopia treatment segment is estimated to witness significant growth during the forecast period.
The market is witnessing significant activity as myopia, a refractive error causing blurred vision, becomes a global health concern due to its increasing prevalence. Non-surgical treatments, such as prescription lenses, play a pivotal role in this market. For instance, eyeglasses and contact lenses, including concave lenses for myopia, help redirect light onto the retina for improved visual acuity. Moreover, advancements in technology have led to the integration of machine learning and computer vision syndrome in digital health solutions for eye care. These technologies enable personalized medicine and remote monitoring, enhancing patient engagement and satisfaction. Additionally, research and development in the field of refractive surgery and surgical procedures offer long-term vision correction solutions.
Eye care professionals emphasize the importance of maintaining a healthy eye care routine and adopting lifestyle changes to mitigate myopic symptoms. Presbyopia, an age-related vision loss condition, also requires correction, leading to the development of multifocal intraocular lenses and presbyopic correction methods. Furthermore, patient education and awareness campaigns address digital eye strain and ocular surface diseases like dry eye. Clinical trials and image analysis contribute to the market's growth by providing insights into the effectiveness of various treatment options and improving treatment outcomes. In summary, the market is evolving, with a focus on patient-centric solutions that cater to diverse vision needs.
The Myopia treatment segment was valued at USD 7.68 billion in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
Asia is estimated to contribute 37% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market is experiencing significant advancements, driven by the increasing prevalence of these conditions and the development of innovative solutions. Non-surgical treatments, such as orthokeratology and atropine therapy, are gaining popularity for myopia control. Prescription lenses, including progressive lenses and multifocal contact lenses, continue to be the primary solution for presbyopia correction. Machine learning and artificial intelligence are being integrated into digital health platforms to improve patient education and personalized medicine, addressing the unique needs of each individual. Computer vision syndrome and digital eye strain are becoming increasingly common due to prolonged screen time, leading to a rise in demand for remote monitoring and eye drops.
Near vision and distance vision correction options, including refractive surgery and surgical procedures, offer effective solutions for those with severe symptoms. Patient engagement is a key focus, with mobile apps, awareness campaigns, and clinical trials driving early detection and treatment. Eye care professionals are working to promote healthy habits, such as regular eye exams and lifestyle changes, to prevent and manage myopic symptoms. Age-related vision loss, including presbyopia and ocular surface disease, is being addressed through intraocular lenses and dry eye treatments. Patient satisfaction is a priority, with research and development efforts focused on improving treatment outcomes and increasing accessibility.
Image analysis and multifocal iols are revolutionizing presbyopia correction, while clinical trials explore new possibilities for myopia control and presbyopic symptoms. The market is expected to grow, with a strong emphasis on patient education and increasing awareness of eye health.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the Myopia And Presbyopia Treatment market drivers leading to the rise in the adoption of Industry?
- The market is significantly driven by the rising prevalence of myopia and presbyopia, two common vision conditions that necessitate the use of corrective lenses.
- Myopia and presbyopia, two common refractive errors, are causing significant vision impairment worldwide. According to the World Health Organization (WHO), approximately 2.2 billion people had near or distant vision impairment as of October 2021. Uncorrected refractive errors, including myopia and presbyopia, are the primary causes of vision impairment and blindness. Myopia, also known as nearsightedness, is a leading cause of distance vision impairment, with its prevalence increasing from 1.4 to 3 in 2020. The number of people affected by myopia is projected to reach half of the world's population by 2050. To address these vision issues, advanced solutions such as image analysis, multifocal intraocular lenses (IOLs), patient engagement tools like mobile apps, and contact lenses are being explored.
- Clinical trials are ongoing to evaluate the safety and efficacy of these treatments for age-related vision loss. By prioritizing eye health and utilizing these innovative technologies, we can help mitigate the impact of myopia and presbyopia on individuals' quality of life.
What are the Myopia And Presbyopia Treatment market trends shaping the Industry?
- Myopia and presbyopia treatment are currently experiencing significant advancements, representing a notable trend in the ophthalmology market. The ongoing research and development in these areas aim to address the increasing prevalence of these vision conditions and improve the overall quality of care for patients.
- The market is witnessing innovation with companies introducing new products to cater to diverse vision correction needs. In June 2022, Johnson & Johnson unveiled its latest contact lens offerings, ACUVUE OASYS MAX 1-Day and ACUVUE OASYS MAX 1-Day MULTIFOCAL, receiving US FDA clearance, Health Canada approval, and CE Mark. These contact lenses offer all-day comfort and visual clarity, available in spherical and multifocal options. With the increasing prevalence of digital health and computer vision syndrome, the demand for non-surgical treatments like prescription lenses is on the rise.
- Eye care professionals recommend maintaining a healthy eye care routine, including healthy habits, to manage myopic symptoms. Machine learning and computer vision technology are also playing a significant role in personalized medicine, enabling customized treatment plans. Refractive surgery remains an option for severe cases, but non-surgical treatments continue to dominate the market due to their convenience and effectiveness.
How does Myopia And Presbyopia Treatment market faces challenges face during its growth?
- The escalating costs associated with addressing myopia and presbyopia, two prevalent vision conditions, pose a significant challenge to the optometry industry's growth trajectory.
- Myopia and presbyopia, two common vision conditions, require various treatment methods to improve visual acuity. Surgical procedures, such as LASIK and PRK, offer permanent solutions for correcting refractive errors, but they come with higher costs and potential risks. In contrast, eye drops, such as pilocarpine and brimonidine, provide temporary relief for presbyopia symptoms, but require consistent usage and may have side effects. Moreover, the increasing use of digital devices and prolonged screen time can lead to eye strain, exacerbating myopia and presbyopia symptoms. Remote monitoring and patient education are essential to mitigate the negative effects of digital eye strain.
- Artificial intelligence and machine learning algorithms can also assist in diagnosing and monitoring vision conditions, improving treatment outcomes. Lifestyle changes, such as practicing the 20-20-20 rule and incorporating regular exercise, can help manage myopia and presbyopia. Near vision correction methods, such as multifocal contact lenses and reading glasses, are also viable options for those with presbyopia. Despite the various treatment options, the high cost remains a significant challenge for patients and healthcare providers. The global market for myopia and presbyopia treatment continues to evolve, with ongoing research and innovation aimed at addressing the financial and accessibility barriers to effective care.
Exclusive Customer Landscape
The myopia and presbyopia treatment market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the myopia and presbyopia treatment market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, myopia and presbyopia treatment market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
AbbVie Inc. - The company specializes in the treatment of myopia and presbyopia utilizing innovative ophthalmic solutions.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- AbbVie Inc.
- Alcon Inc.
- Arctic Vision
- Bausch Health Companies Inc.
- BVI Holdings Ltd.
- Carl Zeiss AG
- ENTOD INTERNATIONAL
- EssilorLuxottica
- Evotec SE
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Services Inc.
- Metall Zug AG
- NIDEK Co. Ltd.
- Ophtec BV
- Orasis Pharmaceuticals Inc.
- Regeneron Pharmaceuticals Inc.
- Sanjeevan School For Perfect Eyesight
- Sydnexis Inc.
- The Cooper Companies Inc.
- Topcon Corp.
- Vision Care Group
- Visus Therapeutics Inc.
- Ziemer Ophthalmic Systems AG
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Myopia And Presbyopia Treatment Market
- In February 2024, Alcon, a leading global ophthalmic pharmaceutical and surgical company, announced the FDA approval of its new presbyopia treatment, the Acuvue Brillon Multifocal contact lenses. This innovative product, featuring a unique optic design, offers improved visual acuity for both distance and near vision (Alcon press release, 2024).
- In June 2025, Novartis and Google teamed up to form a strategic partnership, combining Novartis' ophthalmology expertise with Google's advanced technology. Their collaboration aims to develop Smart Glasses for myopia treatment, using Google's technology to monitor and correct vision in real-time (Novartis press release, 2025).
- In September 2024, Johnson & Johnson Vision, a worldwide leader in eye health, completed the acquisition of TearScience, a company specializing in the development and commercialization of ocular surface treatment systems. This acquisition strengthens Johnson & Johnson Vision's position in the market, expanding its product offerings and enhancing its ability to address various eye health conditions (Johnson & Johnson Vision press release, 2024).
- In December 2025, the European Commission approved the use of the Light Adjustable Lens (LAL) technology by Swiss company, Alcon. This approval marks a significant advancement in presbyopia treatment, as the LAL technology allows for customized lens adjustments to meet individual patients' visual needs (European Commission press release, 2025).
Research Analyst Overview
The market continues to evolve, driven by advancements in technology and shifting consumer preferences. Non-surgical treatments, such as eye drops and corrective lenses, remain popular options for managing myopic symptoms and presbyopic symptoms. Prescription lenses, including multifocal and progressive lenses, cater to the varying vision needs of individuals. Machine learning and computer vision syndrome are increasingly relevant in the eye care sector. Digital health solutions, including remote monitoring and mobile apps, enable early detection and personalized medicine. Eye care professionals play a crucial role in patient education, promoting healthy habits and lifestyle changes to optimize eye health.
Refractive surgery, while a surgical procedure, continues to advance with innovations in technology, such as image analysis and artificial intelligence. Intraocular lenses and personalized medicine offer promising treatment outcomes for age-related vision loss. Patient satisfaction and engagement are key focus areas, with awareness campaigns targeting conditions like dry eye and presbyopia correction. Ongoing research and development in areas like ocular surface disease and clinical trials contribute to the dynamic nature of the market. The integration of technology, such as AI and machine learning, in eye care routine enhances the diagnostic and therapeutic capabilities of eye care professionals.
The market's continuous unfolding reflects the evolving patterns and applications across various sectors, ensuring a robust and innovative landscape.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Myopia And Presbyopia Treatment Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
170 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.05% |
|
Market growth 2024-2028 |
USD 9755 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
8.1 |
|
Key countries |
US, China, Germany, Canada, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Myopia And Presbyopia Treatment Market Research and Growth Report?
- CAGR of the Myopia And Presbyopia Treatment industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across Asia, North America, Europe, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the myopia and presbyopia treatment market growth of industry companies
We can help! Our analysts can customize this myopia and presbyopia treatment market research report to meet your requirements.
RIA - 
